PETS — PetMed Express Inc · rev $179.0M

PetMed Express Inc (PETS) is a pharmaceutical retailers company listed on NASDAQ.

Latest reported PETS revenue for 2026-03-31 was $179.0M. Net income was -$57.3M. Revenue was down 21.1% from 2025-03-31 to 2026-03-31. PETS currently screens at market cap $38.5M.

Use this PETS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PETS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PETS SEC filings page. Lician reads the product cache first so this HTML stays unique to PetMed Express Inc even when a live quote feed is slow.

PetMed Express Inc latest statements (FY2026)

Latest cached year on this hub. Full PETS income, balance, and cash tables.

  • Revenue$179.0M
  • Net Income-$57.3M
  • Total Assets$81.2M
  • Total Debt$0
  • Free Cash Flow-$33.0M

PETS recent filings